Market Intelligence chevron_right Pharma & Healthcare chevron_right Antiviral Medications for Seasonal Influenza
Global Report 2025

Global Antiviral Medications for Seasonal Influenza Market Growth 2025-2031

calendar_todayPublished: Mar 2025 descriptionPages: 80 categoryCategory: Pharma & Healthcare
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Scope of the Report
 1.1 Market Introduction
 1.2 Years Considered
 1.3 Research Objectives
 1.4 Market Research Methodology
 1.5 Research Process and Data Source
 1.6 Economic Indicators
 1.7 Currency Considered
 1.8 Market Estimation Caveats
2 Executive Summary
 2.1 World Market Overview
 2.1.1 Global Antiviral Medications for Seasonal Influenza Annual Sales 2020-2031
 2.1.2 World Current & Future Analysis for Antiviral Medications for Seasonal Influenza by Geographic Region, 2020, 2024 & 2031
 2.1.3 World Current & Future Analysis for Antiviral Medications for Seasonal Influenza by Country/Region, 2020, 2024 & 2031
 2.2 Antiviral Medications for Seasonal Influenza Segment by Type
 2.2.1 Baloxavir marboxil
 2.2.2 Oseltamivir
 2.2.3 Zanamivir
 2.2.4 Peramivir
 2.3 Antiviral Medications for Seasonal Influenza Sales by Type
 2.3.1 Global Antiviral Medications for Seasonal Influenza Sales Market Share by Type (2020-2025)
 2.3.2 Global Antiviral Medications for Seasonal Influenza Revenue and Market Share by Type (2020-2025)
 2.3.3 Global Antiviral Medications for Seasonal Influenza Sale Price by Type (2020-2025)
 2.4 Antiviral Medications for Seasonal Influenza Segment by Application
 2.4.1 Influenza A
 2.4.2 Influenza B
 2.5 Antiviral Medications for Seasonal Influenza Sales by Application
 2.5.1 Global Antiviral Medications for Seasonal Influenza Sale Market Share by Application (2020-2025)
 2.5.2 Global Antiviral Medications for Seasonal Influenza Revenue and Market Share by Application (2020-2025)
 2.5.3 Global Antiviral Medications for Seasonal Influenza Sale Price by Application (2020-2025) 
3 Global by Company
 3.1 Global Antiviral Medications for Seasonal Influenza Breakdown Data by Company
 3.1.1 Global Antiviral Medications for Seasonal Influenza Annual Sales by Company (2020-2025)
 3.1.2 Global Antiviral Medications for Seasonal Influenza Sales Market Share by Company (2020-2025)
 3.2 Global Antiviral Medications for Seasonal Influenza Annual Revenue by Company (2020-2025)
 3.2.1 Global Antiviral Medications for Seasonal Influenza Revenue by Company (2020-2025)
 3.2.2 Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Company (2020-2025)
 3.3 Global Antiviral Medications for Seasonal Influenza Sale Price by Company
 3.4 Key Manufacturers Antiviral Medications for Seasonal Influenza Producing Area Distribution, Sales Area, Product Type
 3.4.1 Key Manufacturers Antiviral Medications for Seasonal Influenza Product Location Distribution
 3.4.2 Players Antiviral Medications for Seasonal Influenza Products Offered
 3.5 Market Concentration Rate Analysis
 3.5.1 Competition Landscape Analysis
 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 3.6 New Products and Potential Entrants
 3.7 Market M&A Activity & Strategy
4 World Historic Review for Antiviral Medications for Seasonal Influenza by Geographic Region
 4.1 World Historic Antiviral Medications for Seasonal Influenza Market Size by Geographic Region (2020-2025)
 4.1.1 Global Antiviral Medications for Seasonal Influenza Annual Sales by Geographic Region (2020-2025)
 4.1.2 Global Antiviral Medications for Seasonal Influenza Annual Revenue by Geographic Region (2020-2025)
 4.2 World Historic Antiviral Medications for Seasonal Influenza Market Size by Country/Region (2020-2025)
 4.2.1 Global Antiviral Medications for Seasonal Influenza Annual Sales by Country/Region (2020-2025)
 4.2.2 Global Antiviral Medications for Seasonal Influenza Annual Revenue by Country/Region (2020-2025)
 4.3 Americas Antiviral Medications for Seasonal Influenza Sales Growth
 4.4 APAC Antiviral Medications for Seasonal Influenza Sales Growth
 4.5 Europe Antiviral Medications for Seasonal Influenza Sales Growth
 4.6 Middle East & Africa Antiviral Medications for Seasonal Influenza Sales Growth
5 Americas
 5.1 Americas Antiviral Medications for Seasonal Influenza Sales by Country
 5.1.1 Americas Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025)
 5.1.2 Americas Antiviral Medications for Seasonal Influenza Revenue by Country (2020-2025)
 5.2 Americas Antiviral Medications for Seasonal Influenza Sales by Type (2020-2025)
 5.3 Americas Antiviral Medications for Seasonal Influenza Sales by Application (2020-2025)
 5.4 United States
 5.5 Canada
 5.6 Mexico
 5.7 Brazil
6 APAC
 6.1 APAC Antiviral Medications for Seasonal Influenza Sales by Region
 6.1.1 APAC Antiviral Medications for Seasonal Influenza Sales by Region (2020-2025)
 6.1.2 APAC Antiviral Medications for Seasonal Influenza Revenue by Region (2020-2025)
 6.2 APAC Antiviral Medications for Seasonal Influenza Sales by Type (2020-2025)
 6.3 APAC Antiviral Medications for Seasonal Influenza Sales by Application (2020-2025)
 6.4 China
 6.5 Japan
 6.6 South Korea
 6.7 Southeast Asia
 6.8 India
 6.9 Australia
 6.10 China Taiwan
7 Europe
 7.1 Europe Antiviral Medications for Seasonal Influenza by Country
 7.1.1 Europe Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025)
 7.1.2 Europe Antiviral Medications for Seasonal Influenza Revenue by Country (2020-2025)
 7.2 Europe Antiviral Medications for Seasonal Influenza Sales by Type (2020-2025)
 7.3 Europe Antiviral Medications for Seasonal Influenza Sales by Application (2020-2025)
 7.4 Germany
 7.5 France
 7.6 UK
 7.7 Italy
 7.8 Russia
8 Middle East & Africa
 8.1 Middle East & Africa Antiviral Medications for Seasonal Influenza by Country
 8.1.1 Middle East & Africa Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025)
 8.1.2 Middle East & Africa Antiviral Medications for Seasonal Influenza Revenue by Country (2020-2025)
 8.2 Middle East & Africa Antiviral Medications for Seasonal Influenza Sales by Type (2020-2025)
 8.3 Middle East & Africa Antiviral Medications for Seasonal Influenza Sales by Application (2020-2025)
 8.4 Egypt
 8.5 South Africa
 8.6 Israel
 8.7 Turkey
 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
 9.1 Market Drivers & Growth Opportunities
 9.2 Market Challenges & Risks
 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
 10.1 Raw Material and Suppliers
 10.2 Manufacturing Cost Structure Analysis of Antiviral Medications for Seasonal Influenza
 10.3 Manufacturing Process Analysis of Antiviral Medications for Seasonal Influenza
 10.4 Industry Chain Structure of Antiviral Medications for Seasonal Influenza
11 Marketing, Distributors and Customer
 11.1 Sales Channel
 11.1.1 Direct Channels
 11.1.2 Indirect Channels
 11.2 Antiviral Medications for Seasonal Influenza Distributors
 11.3 Antiviral Medications for Seasonal Influenza Customer
12 World Forecast Review for Antiviral Medications for Seasonal Influenza by Geographic Region
 12.1 Global Antiviral Medications for Seasonal Influenza Market Size Forecast by Region
 12.1.1 Global Antiviral Medications for Seasonal Influenza Forecast by Region (2026-2031)
 12.1.2 Global Antiviral Medications for Seasonal Influenza Annual Revenue Forecast by Region (2026-2031)
 12.2 Americas Forecast by Country (2026-2031)
 12.3 APAC Forecast by Region (2026-2031)
 12.4 Europe Forecast by Country (2026-2031)
 12.5 Middle East & Africa Forecast by Country (2026-2031)
 12.6 Global Antiviral Medications for Seasonal Influenza Forecast by Type (2026-2031)
 12.7 Global Antiviral Medications for Seasonal Influenza Forecast by Application (2026-2031)
13 Key Players Analysis
 13.1 Roche
 13.1.1 Roche Company Information
 13.1.2 Roche Antiviral Medications for Seasonal Influenza Product Portfolios and Specifications
 13.1.3 Roche Antiviral Medications for Seasonal Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
 13.1.4 Roche Main Business Overview
 13.1.5 Roche Latest Developments
 13.2 HEC Pharma
 13.2.1 HEC Pharma Company Information
 13.2.2 HEC Pharma Antiviral Medications for Seasonal Influenza Product Portfolios and Specifications
 13.2.3 HEC Pharma Antiviral Medications for Seasonal Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
 13.2.4 HEC Pharma Main Business Overview
 13.2.5 HEC Pharma Latest Developments
 13.3 Qilu Pharmaceutical
 13.3.1 Qilu Pharmaceutical Company Information
 13.3.2 Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Product Portfolios and Specifications
 13.3.3 Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
 13.3.4 Qilu Pharmaceutical Main Business Overview
 13.3.5 Qilu Pharmaceutical Latest Developments
 13.4 CSPC
 13.4.1 CSPC Company Information
 13.4.2 CSPC Antiviral Medications for Seasonal Influenza Product Portfolios and Specifications
 13.4.3 CSPC Antiviral Medications for Seasonal Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
 13.4.4 CSPC Main Business Overview
 13.4.5 CSPC Latest Developments
 13.5 Kelun
 13.5.1 Kelun Company Information
 13.5.2 Kelun Antiviral Medications for Seasonal Influenza Product Portfolios and Specifications
 13.5.3 Kelun Antiviral Medications for Seasonal Influenza Sales, Revenue, Price and Gross Margin (2020-2025)
 13.5.4 Kelun Main Business Overview
 13.5.5 Kelun Latest Developments
14 Research Findings and Conclusion

List of Tables
 Table 1. Antiviral Medications for Seasonal Influenza Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Antiviral Medications for Seasonal Influenza Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Baloxavir marboxil
 Table 4. Major Players of Oseltamivir
 Table 5. Major Players of Zanamivir
 Table 6. Major Players of Peramivir
 Table 7. Global Antiviral Medications for Seasonal Influenza Sales by Type (2020-2025) & (kg)
 Table 8. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Type (2020-2025)
 Table 9. Global Antiviral Medications for Seasonal Influenza Revenue by Type (2020-2025) & ($ million)
 Table 10. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Type (2020-2025)
 Table 11. Global Antiviral Medications for Seasonal Influenza Sale Price by Type (2020-2025) & (US$/g)
 Table 12. Global Antiviral Medications for Seasonal Influenza Sale by Application (2020-2025) & (kg)
 Table 13. Global Antiviral Medications for Seasonal Influenza Sale Market Share by Application (2020-2025)
 Table 14. Global Antiviral Medications for Seasonal Influenza Revenue by Application (2020-2025) & ($ million)
 Table 15. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Application (2020-2025)
 Table 16. Global Antiviral Medications for Seasonal Influenza Sale Price by Application (2020-2025) & (US$/g)
 Table 17. Global Antiviral Medications for Seasonal Influenza Sales by Company (2020-2025) & (kg)
 Table 18. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Company (2020-2025)
 Table 19. Global Antiviral Medications for Seasonal Influenza Revenue by Company (2020-2025) & ($ millions)
 Table 20. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Company (2020-2025)
 Table 21. Global Antiviral Medications for Seasonal Influenza Sale Price by Company (2020-2025) & (US$/g)
 Table 22. Key Manufacturers Antiviral Medications for Seasonal Influenza Producing Area Distribution and Sales Area
 Table 23. Players Antiviral Medications for Seasonal Influenza Products Offered
 Table 24. Antiviral Medications for Seasonal Influenza Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 25. New Products and Potential Entrants
 Table 26. Market M&A Activity & Strategy
 Table 27. Global Antiviral Medications for Seasonal Influenza Sales by Geographic Region (2020-2025) & (kg)
 Table 28. Global Antiviral Medications for Seasonal Influenza Sales Market Share Geographic Region (2020-2025)
 Table 29. Global Antiviral Medications for Seasonal Influenza Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 30. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Geographic Region (2020-2025)
 Table 31. Global Antiviral Medications for Seasonal Influenza Sales by Country/Region (2020-2025) & (kg)
 Table 32. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Country/Region (2020-2025)
 Table 33. Global Antiviral Medications for Seasonal Influenza Revenue by Country/Region (2020-2025) & ($ millions)
 Table 34. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Country/Region (2020-2025)
 Table 35. Americas Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025) & (kg)
 Table 36. Americas Antiviral Medications for Seasonal Influenza Sales Market Share by Country (2020-2025)
 Table 37. Americas Antiviral Medications for Seasonal Influenza Revenue by Country (2020-2025) & ($ millions)
 Table 38. Americas Antiviral Medications for Seasonal Influenza Sales by Type (2020-2025) & (kg)
 Table 39. Americas Antiviral Medications for Seasonal Influenza Sales by Application (2020-2025) & (kg)
 Table 40. APAC Antiviral Medications for Seasonal Influenza Sales by Region (2020-2025) & (kg)
 Table 41. APAC Antiviral Medications for Seasonal Influenza Sales Market Share by Region (2020-2025)
 Table 42. APAC Antiviral Medications for Seasonal Influenza Revenue by Region (2020-2025) & ($ millions)
 Table 43. APAC Antiviral Medications for Seasonal Influenza Sales by Type (2020-2025) & (kg)
 Table 44. APAC Antiviral Medications for Seasonal Influenza Sales by Application (2020-2025) & (kg)
 Table 45. Europe Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025) & (kg)
 Table 46. Europe Antiviral Medications for Seasonal Influenza Revenue by Country (2020-2025) & ($ millions)
 Table 47. Europe Antiviral Medications for Seasonal Influenza Sales by Type (2020-2025) & (kg)
 Table 48. Europe Antiviral Medications for Seasonal Influenza Sales by Application (2020-2025) & (kg)
 Table 49. Middle East & Africa Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025) & (kg)
 Table 50. Middle East & Africa Antiviral Medications for Seasonal Influenza Revenue Market Share by Country (2020-2025)
 Table 51. Middle East & Africa Antiviral Medications for Seasonal Influenza Sales by Type (2020-2025) & (kg)
 Table 52. Middle East & Africa Antiviral Medications for Seasonal Influenza Sales by Application (2020-2025) & (kg)
 Table 53. Key Market Drivers & Growth Opportunities of Antiviral Medications for Seasonal Influenza
 Table 54. Key Market Challenges & Risks of Antiviral Medications for Seasonal Influenza
 Table 55. Key Industry Trends of Antiviral Medications for Seasonal Influenza
 Table 56. Antiviral Medications for Seasonal Influenza Raw Material
 Table 57. Key Suppliers of Raw Materials
 Table 58. Antiviral Medications for Seasonal Influenza Distributors List
 Table 59. Antiviral Medications for Seasonal Influenza Customer List
 Table 60. Global Antiviral Medications for Seasonal Influenza Sales Forecast by Region (2026-2031) & (kg)
 Table 61. Global Antiviral Medications for Seasonal Influenza Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 62. Americas Antiviral Medications for Seasonal Influenza Sales Forecast by Country (2026-2031) & (kg)
 Table 63. Americas Antiviral Medications for Seasonal Influenza Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 64. APAC Antiviral Medications for Seasonal Influenza Sales Forecast by Region (2026-2031) & (kg)
 Table 65. APAC Antiviral Medications for Seasonal Influenza Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 66. Europe Antiviral Medications for Seasonal Influenza Sales Forecast by Country (2026-2031) & (kg)
 Table 67. Europe Antiviral Medications for Seasonal Influenza Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Middle East & Africa Antiviral Medications for Seasonal Influenza Sales Forecast by Country (2026-2031) & (kg)
 Table 69. Middle East & Africa Antiviral Medications for Seasonal Influenza Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 70. Global Antiviral Medications for Seasonal Influenza Sales Forecast by Type (2026-2031) & (kg)
 Table 71. Global Antiviral Medications for Seasonal Influenza Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 72. Global Antiviral Medications for Seasonal Influenza Sales Forecast by Application (2026-2031) & (kg)
 Table 73. Global Antiviral Medications for Seasonal Influenza Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 74. Roche Basic Information, Antiviral Medications for Seasonal Influenza Manufacturing Base, Sales Area and Its Competitors
 Table 75. Roche Antiviral Medications for Seasonal Influenza Product Portfolios and Specifications
 Table 76. Roche Antiviral Medications for Seasonal Influenza Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 77. Roche Main Business
 Table 78. Roche Latest Developments
 Table 79. HEC Pharma Basic Information, Antiviral Medications for Seasonal Influenza Manufacturing Base, Sales Area and Its Competitors
 Table 80. HEC Pharma Antiviral Medications for Seasonal Influenza Product Portfolios and Specifications
 Table 81. HEC Pharma Antiviral Medications for Seasonal Influenza Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 82. HEC Pharma Main Business
 Table 83. HEC Pharma Latest Developments
 Table 84. Qilu Pharmaceutical Basic Information, Antiviral Medications for Seasonal Influenza Manufacturing Base, Sales Area and Its Competitors
 Table 85. Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Product Portfolios and Specifications
 Table 86. Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 87. Qilu Pharmaceutical Main Business
 Table 88. Qilu Pharmaceutical Latest Developments
 Table 89. CSPC Basic Information, Antiviral Medications for Seasonal Influenza Manufacturing Base, Sales Area and Its Competitors
 Table 90. CSPC Antiviral Medications for Seasonal Influenza Product Portfolios and Specifications
 Table 91. CSPC Antiviral Medications for Seasonal Influenza Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 92. CSPC Main Business
 Table 93. CSPC Latest Developments
 Table 94. Kelun Basic Information, Antiviral Medications for Seasonal Influenza Manufacturing Base, Sales Area and Its Competitors
 Table 95. Kelun Antiviral Medications for Seasonal Influenza Product Portfolios and Specifications
 Table 96. Kelun Antiviral Medications for Seasonal Influenza Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 97. Kelun Main Business
 Table 98. Kelun Latest Developments


List of Figures
 Figure 1. Picture of Antiviral Medications for Seasonal Influenza
 Figure 2. Antiviral Medications for Seasonal Influenza Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Antiviral Medications for Seasonal Influenza Sales Growth Rate 2020-2031 (kg)
 Figure 7. Global Antiviral Medications for Seasonal Influenza Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Antiviral Medications for Seasonal Influenza Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Antiviral Medications for Seasonal Influenza Sales Market Share by Country/Region (2024)
 Figure 10. Antiviral Medications for Seasonal Influenza Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Baloxavir marboxil
 Figure 12. Product Picture of Oseltamivir
 Figure 13. Product Picture of Zanamivir
 Figure 14. Product Picture of Peramivir
 Figure 15. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Type in 2025
 Figure 16. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Type (2020-2025)
 Figure 17. Antiviral Medications for Seasonal Influenza Consumed in Influenza A
 Figure 18. Global Antiviral Medications for Seasonal Influenza Market: Influenza A (2020-2025) & (kg)
 Figure 19. Antiviral Medications for Seasonal Influenza Consumed in Influenza B
 Figure 20. Global Antiviral Medications for Seasonal Influenza Market: Influenza B (2020-2025) & (kg)
 Figure 21. Global Antiviral Medications for Seasonal Influenza Sale Market Share by Application (2024)
 Figure 22. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Application in 2025
 Figure 23. Antiviral Medications for Seasonal Influenza Sales by Company in 2025 (kg)
 Figure 24. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Company in 2025
 Figure 25. Antiviral Medications for Seasonal Influenza Revenue by Company in 2025 ($ millions)
 Figure 26. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Company in 2025
 Figure 27. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Geographic Region (2020-2025)
 Figure 28. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Geographic Region in 2025
 Figure 29. Americas Antiviral Medications for Seasonal Influenza Sales 2020-2025 (kg)
 Figure 30. Americas Antiviral Medications for Seasonal Influenza Revenue 2020-2025 ($ millions)
 Figure 31. APAC Antiviral Medications for Seasonal Influenza Sales 2020-2025 (kg)
 Figure 32. APAC Antiviral Medications for Seasonal Influenza Revenue 2020-2025 ($ millions)
 Figure 33. Europe Antiviral Medications for Seasonal Influenza Sales 2020-2025 (kg)
 Figure 34. Europe Antiviral Medications for Seasonal Influenza Revenue 2020-2025 ($ millions)
 Figure 35. Middle East & Africa Antiviral Medications for Seasonal Influenza Sales 2020-2025 (kg)
 Figure 36. Middle East & Africa Antiviral Medications for Seasonal Influenza Revenue 2020-2025 ($ millions)
 Figure 37. Americas Antiviral Medications for Seasonal Influenza Sales Market Share by Country in 2025
 Figure 38. Americas Antiviral Medications for Seasonal Influenza Revenue Market Share by Country (2020-2025)
 Figure 39. Americas Antiviral Medications for Seasonal Influenza Sales Market Share by Type (2020-2025)
 Figure 40. Americas Antiviral Medications for Seasonal Influenza Sales Market Share by Application (2020-2025)
 Figure 41. United States Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 42. Canada Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 43. Mexico Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 44. Brazil Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 45. APAC Antiviral Medications for Seasonal Influenza Sales Market Share by Region in 2025
 Figure 46. APAC Antiviral Medications for Seasonal Influenza Revenue Market Share by Region (2020-2025)
 Figure 47. APAC Antiviral Medications for Seasonal Influenza Sales Market Share by Type (2020-2025)
 Figure 48. APAC Antiviral Medications for Seasonal Influenza Sales Market Share by Application (2020-2025)
 Figure 49. China Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 50. Japan Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 51. South Korea Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 52. Southeast Asia Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 53. India Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 54. Australia Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 55. China Taiwan Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 56. Europe Antiviral Medications for Seasonal Influenza Sales Market Share by Country in 2025
 Figure 57. Europe Antiviral Medications for Seasonal Influenza Revenue Market Share by Country (2020-2025)
 Figure 58. Europe Antiviral Medications for Seasonal Influenza Sales Market Share by Type (2020-2025)
 Figure 59. Europe Antiviral Medications for Seasonal Influenza Sales Market Share by Application (2020-2025)
 Figure 60. Germany Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 61. France Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 62. UK Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 63. Italy Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 64. Russia Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 65. Middle East & Africa Antiviral Medications for Seasonal Influenza Sales Market Share by Country (2020-2025)
 Figure 66. Middle East & Africa Antiviral Medications for Seasonal Influenza Sales Market Share by Type (2020-2025)
 Figure 67. Middle East & Africa Antiviral Medications for Seasonal Influenza Sales Market Share by Application (2020-2025)
 Figure 68. Egypt Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 69. South Africa Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 70. Israel Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 71. Turkey Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 72. GCC Countries Antiviral Medications for Seasonal Influenza Revenue Growth 2020-2025 ($ millions)
 Figure 73. Manufacturing Cost Structure Analysis of Antiviral Medications for Seasonal Influenza in 2025
 Figure 74. Manufacturing Process Analysis of Antiviral Medications for Seasonal Influenza
 Figure 75. Industry Chain Structure of Antiviral Medications for Seasonal Influenza
 Figure 76. Channels of Distribution
 Figure 77. Global Antiviral Medications for Seasonal Influenza Sales Market Forecast by Region (2026-2031)
 Figure 78. Global Antiviral Medications for Seasonal Influenza Revenue Market Share Forecast by Region (2026-2031)
 Figure 79. Global Antiviral Medications for Seasonal Influenza Sales Market Share Forecast by Type (2026-2031)
 Figure 80. Global Antiviral Medications for Seasonal Influenza Revenue Market Share Forecast by Type (2026-2031)
 Figure 81. Global Antiviral Medications for Seasonal Influenza Sales Market Share Forecast by Application (2026-2031)
 Figure 82. Global Antiviral Medications for Seasonal Influenza Revenue Market Share Forecast by Application (2026-2031)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche|||HEC Pharma|||Qilu Pharmaceutical|||CSPC|||Kelun

Frequently Asked Questions

What is the USP of the report? expand_more
Antiviral Medications for Seasonal Influenza report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Antiviral Medications for Seasonal Influenza report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Antiviral Medications for Seasonal Influenza report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.